CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity ; volume:14 ; number:3 ; day:23 ; month:5 ; year:2012 ; pages:1-19 ; date:6.2012
Breast cancer research ; 14, Heft 3 (23.5.2012), 1-19, 6.2012
- Urheber
-
Montgomery, Nicola
- Beteiligte Personen und Organisationen
-
Hill, Ashleigh
McFarlane, Suzanne
Neisen, Jessica
O'Grady, Anthony
Conlon, Susie
Jirstrom, Karin
Kay, Elaine W.
Waugh, David JJ
SpringerLink (Online service)
- DOI
-
10.1186/bcr3199
- URN
-
urn:nbn:de:1111-2016032415045
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Montgomery, Nicola
- Hill, Ashleigh
- McFarlane, Suzanne
- Neisen, Jessica
- O'Grady, Anthony
- Conlon, Susie
- Jirstrom, Karin
- Kay, Elaine W.
- Waugh, David JJ
- SpringerLink (Online service)
Ähnliche Objekte (12)
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms